BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24052081)

  • 1. Renal interstitial fibrosis in 0-hour biopsy as a predictor of post-transplant anemia.
    Tsuchimoto A; Masutani K; Haruyama N; Nagata M; Noguchi H; Okabe Y; Kitada H; Tanaka M; Tsuruya K; Kitazono T
    Am J Nephrol; 2013; 38(4):267-74. PubMed ID: 24052081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria is a predictor of posttransplant anemia.
    Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
    Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy.
    Akioka Y; Chikamoto H; Horita S; Yago R; Tanabe K; Yamaguchi Y; Hattori M
    Clin Transplant; 2009 Aug; 23 Suppl 20():2-5. PubMed ID: 19594587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsies in renal transplant patients with proteinuria: histological findings.
    López V; Sola E; Jironda C; León M; García I; Gutierrez C; Cabello M; Burgos D; González-Molina M; Hernandez D
    Transplant Proc; 2011; 43(6):2191-3. PubMed ID: 21839230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T; Toma H; Hayakawa N; Shibahara R; Ishiyama R; Hayashida A; Fujimori D; Tsunoyama K; Ikezawa E; Kitajima S; Iida S; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Associated factors and clinical implications of post transplant renal anemia].
    Freiberg M; Chiurchiu C; Capra R; Eckhardt A; De La Fuente J; Douthat W; De Arteaga J; Massari PU
    Medicina (B Aires); 2013; 73(2):136-40. PubMed ID: 23570761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
    Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
    Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive interstitial fibrosis of kidney allograft early after transplantation from a non-heart beating donor: possible role of persistent ischemic injury.
    Masutani K; Kitada H; Yamada S; Tsuchimoto A; Noguchi H; Tsuruya K; Katafuchi R; Tanaka M; Iida M
    Clin Transplant; 2010 Jul; 24 Suppl 22():70-4. PubMed ID: 20590699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant glomerulopathy: clinical course and factors relating to graft survival.
    López Jiménez V; Fuentes L; Jiménez T; León M; Garcia I; Sola E; Cabello M; Gutierrez C; Burgos D; Ruiz P; Hernandez D
    Transplant Proc; 2012 Nov; 44(9):2599-600. PubMed ID: 23146467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
    Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing levels of hemoglobin improve renal transplantation outcomes.
    Lofaro D; Greco R; Papalia T; Bonofiglio R
    Transplant Proc; 2011 May; 43(4):1036-8. PubMed ID: 21620046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic vascular hemodynamics and transplanted kidney survival.
    Wystrychowski G; Kolonko A; Chudek J; Zukowska-Szczechowska E; Wiecek A; Grzeszczak W
    Transplant Proc; 2011 Oct; 43(8):2922-5. PubMed ID: 21996190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of recurrent glomerulonephritis on renal graft survival.
    Toledo K; Pérez-Sáez MJ; Navarro MD; Ortega R; Redondo MD; Agüera ML; Rodríguez-Benot A; Aljama P
    Transplant Proc; 2011; 43(6):2182-6. PubMed ID: 21839228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
    Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
    Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of time-zero biopsy on early graft outcomes after living donor kidney transplantation.
    Lee AL; Kim YS; Lim BJ; Jeong HJ; Joo DJ; Kim MS; Huh KH
    Transplant Proc; 2013 Oct; 45(8):2937-40. PubMed ID: 24157007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of expanded-criteria donor kidney grafts at lower risk of delayed graft function.
    Balaz P; Rokosny S; Wohlfahrtova M; Wohlfahrt P; Bartonova A; Pokorna E; Honsova E; Viklicky O
    Transplantation; 2013 Oct; 96(7):633-8. PubMed ID: 23912171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney-transplant patients.
    Kamar N; Reboux AH; Cointault O; Esposito L; Cardeau-Desangles I; Lavayssière L; Guitard J; Wéclawiak H; Rostaing L
    Transpl Int; 2010 Mar; 23(3):277-84. PubMed ID: 19821956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of blood transfusion after pediatric kidney transplantation.
    Richards KM; Spicer RA; Craig E; Kennedy SE
    Pediatr Nephrol; 2018 Nov; 33(11):2177-2184. PubMed ID: 30006835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.
    Jones H; Talwar M; Nogueira JM; Ugarte R; Cangro C; Rasheed H; Klassen DK; Weir MR; Haririan A
    Transplantation; 2012 May; 93(9):923-8. PubMed ID: 22377790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.